The development of efficacious prevention strategies targeting cardiovascular risk factors such as hypertension, LDL cholesterol, and other ApoB (apolipoprotein-B) containing lipoproteins has revolutionized the care of these conditions. This evidence concerns the gene APOB and Hypertension.